Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies
Z Lucane, B Slisere, G Gersone, S Papirte, L Gailite… - Viruses, 2023 - mdpi.com
Predominantly antibody deficiencies (PADs) are inborn disorders characterized by immune
dysregulation and increased susceptibility to infections. Response to vaccination, including …
dysregulation and increased susceptibility to infections. Response to vaccination, including …
Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies
D Mizera, R Dziedzic, A Drynda… - Frontiers in …, 2023 - frontiersin.org
Introduction Primary antibody deficiencies (PAD) are inborn defects of the immune system
that result in increased susceptibility to infections. Despite the reduced response to …
that result in increased susceptibility to infections. Despite the reduced response to …
Robust antibody and T cell responses to SARS-CoV-2 in patients with antibody deficiency
H Kinoshita, J Durkee-Shock… - Journal of Clinical …, 2021 - Springer
Immunocompromised patients, including those with inborn errors of immunity (IEI), may be at
increased risk for severe or prolonged infections with SARS-CoV-2 (Zhu et al. N Engl J Med …
increased risk for severe or prolonged infections with SARS-CoV-2 (Zhu et al. N Engl J Med …
Adaptive Cellular Responses following SARS-CoV-2 Vaccination in Primary Antibody Deficiency Patients
S Gupta, H Su, S Agrawal, Y Demirdag, M Tran… - Pathogens, 2024 - mdpi.com
Since the start of the COVID-19 pandemic, in a short span of 3 years, vaccination against
SARS-CoV-2 has resulted in the end of the pandemic. Patients with inborn errors of …
SARS-CoV-2 has resulted in the end of the pandemic. Patients with inborn errors of …
SARS-CoV-2 Vaccine Response Following Five Total Vaccine Doses in Adult Patients with Predominantly Antibody Deficiency (PAD)
A ELMOURSI, A Zhang, D Digiacomo… - Journal of Allergy and …, 2024 - jacionline.org
Methods We evaluated anti-SARS-CoV-2 spike antibody levels in 117 PAD patients post-
immunization over five total SARS-CoV-2 vaccine doses and compared this to data in 192 …
immunization over five total SARS-CoV-2 vaccine doses and compared this to data in 192 …
Long-Term Immunological Memory of SARS-CoV-2 Is Present in Patients with Primary Antibody Deficiencies for up to a Year after Vaccination
Z Lucane, B Slisere, L Ozola, D Rots, S Papirte, B Vilne… - Vaccines, 2023 - mdpi.com
Some studies have found increased coronavirus disease-19 (COVID-19)-related morbidity
and mortality in patients with primary antibody deficiencies. Immunization against COVID-19 …
and mortality in patients with primary antibody deficiencies. Immunization against COVID-19 …
SARS-CoV-2 vaccine induced atypical immune responses in antibody defects: everybody does their best
AF Salinas, EP Mortari, S Terreri, C Quintarelli… - Journal of clinical …, 2021 - Springer
Background Data on immune responses to SARS-CoV-2 in patients with Primary Antibody
Deficiencies (PAD) are limited to infected patients and to heterogeneous cohorts after …
Deficiencies (PAD) are limited to infected patients and to heterogeneous cohorts after …
SARS-CoV-2 vaccine responses in individuals with antibody deficiency: findings from the COV-AD study
Background Vaccination prevents severe morbidity and mortality from COVID-19 in the
general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients …
general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients …
SARS-CoV-2 T cell response in severe and fatal COVID-19 in primary antibody deficiency patients without specific humoral immunity
S Steiner, T Schwarz, VM Corman, L Gebert… - Frontiers in …, 2022 - frontiersin.org
Morbidity and mortality of COVID-19 is increased in patients with inborn errors of immunity
(IEI). Age and comorbidities and also impaired type I interferon immunity were identified as …
(IEI). Age and comorbidities and also impaired type I interferon immunity were identified as …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency
AM Zhang, A Elmoursi, DV DiGiacomo, B Zhou… - Journal of Allergy and …, 2024 - Elsevier
Background Patients with predominantly antibody deficiency (PAD) have lower anti–severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
相关搜索
- sars cov predominantly antibody
- vaccine response predominantly antibody
- sars cov vaccine response
- cytokine response antigen stimulation
- sars cov covid 19
- antibody deficiency cell responses
- sars cov immunological memory
- risk factors predominantly antibody
- immunological memory antibody deficiencies
- sars cov risk factors
- sars cov antibody deficiencies
- vaccine doses predominantly antibody
- sars cov vaccine doses
- antigen stimulation predominantly antibody
- cytokine response predominantly antibody
- sars cov antigen stimulation